Forty-three per cent of older persons’ patient groups represent patient interests to regulators. Meetings with policymakers and representation within governmental advisory bodies are most common (both 40%), while 60% mobilise parliamentarians and political leaders.
43% of respondents from Older people ‘Regularly’ or ‘Sometimes’ represent patient interests to drug regulators
Patient groups representing each Older people sub-type
14 patient groups across 1 sub-types
interactions
We have intervened at price review boards, advocated to policymakers and government officials, been invited to national roundtables by governments and also by pharma, etc.
We often focus on vaccines, but not only those. We have intervened at price review boards, advocated to policymakers and government officials, been invited to national roundtables by governments and also by pharma, etc.
National older-people patient group, Canada
interactions
… We also issue practice recommendations for members of the ESGG [Sociedad Española de Geriatría y Gerontología – Spanish Society of Geriatrics and Gerontology].
Asesoramos a la administración en determinados temas o disposiciones relacionadas con nuestro ámbito de actuación (la persona mayor). Denunciamos cuestiones como las reacciones adversas a medicamentos. También llevamos a cabo determinadas recomendaciones de actuación para los miembros de la Sociedad Española de Geriatría y Gerontología (ESGG). Llevamos a cabo informes periódicos sobre temas muy variados.
National older-people patient group, Spain
actions & advocacy
We often focus on vaccines, but not only those. We have intervened at price review boards, advocated to policymakers and government officials, been invited to national roundtables by governments and also by pharma, etc.
We often focus on vaccines, but not only those. We have intervened at price review boards, advocated to policymakers and government officials, been invited to national roundtables by governments and also by pharma, etc.
National older-people patient group, Canada
actions & advocacy
… We raise concerns on issues such as adverse drug reactions.
Asesoramos a la administración en determinados temas o disposiciones relacionadas con nuestro ámbito de actuación (la persona mayor). Denunciamos cuestiones como las reacciones adversas a medicamentos. También llevamos a cabo determinadas recomendaciones de actuación para los miembros de la Sociedad Española de Geriatría y Gerontología (ESGG). Llevamos a cabo informes periódicos sobre temas muy variados.
National older-people patient group, Spain
The percentages below highlight how the 5 patient groups interact with regulators and advocate for patient interests. As respondents may be represented in more than one area, percentages may not total 100%.
interactions
2 mentions
2 mentions
2 mentions
2 mentions
1 mention
1 mention
1 mention
1 mention
1 mention
1 mention
actions & advocacy
4 mentions
3 mentions
1 mention
1 mention
1 mention
1 mention
1 mention
1 mention
1 mention
GET THE REPORT
Our research covers 2,262 patient groups representing 100 countries and 45 therapy areas. The sample report shows you the depth of analysis for a single country or therapy area. To access any other reports, please get in touch.
Visit patient-view.com to gather more information or email: Alex Wyke, alexwyke@patient-view.com
